Bioventus (NASDAQ:BVS) Trading Up 1.4% – Here’s What Happened

Bioventus Inc. (NASDAQ:BVS)’s share price rose 1.4% during trading on Thursday . The stock traded as high as $8.40 and last traded at $8.21. Approximately 315,175 shares traded hands during trading, an increase of 39% from the average daily volume of 226,423 shares. The stock had previously closed at $8.10.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bioventus in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Bioventus currently has a consensus rating of “Hold”.

Bioventus Trading Up 1.4%

The company has a market capitalization of $679.46 million, a P/E ratio of 68.42 and a beta of 0.80. The company has a quick ratio of 1.14, a current ratio of 1.74 and a debt-to-equity ratio of 1.50. The firm’s 50-day moving average price is $7.68 and its 200 day moving average price is $7.24.

Bioventus (NASDAQ:BVS) last posted its earnings results on Tuesday, November 4th. The company reported $0.15 earnings per share for the quarter. Bioventus had a return on equity of 26.38% and a net margin of 1.39%.The company had revenue of $138.65 million for the quarter.

Bioventus Company Profile

Bioventus, headquartered in Durham, North Carolina, is a global medical device company specializing in orthobiologic solutions aimed at accelerating healing and improving patient outcomes in musculoskeletal conditions. The company develops and commercializes a portfolio of non‐surgical therapies designed to address bone healing, osteoarthritis pain management and soft tissue repair. Its flagship EXOGEN® Ultrasound Bone Healing System utilizes low‐intensity pulsed ultrasound technology to stimulate bone growth and has been widely used in the management of delayed fractures and nonunions.